ResMed Inc. last reported quarterly results on Oct 29, 2026, for Q1 FY2027 (the quarter ended Sep 30, 2026): revenue of $1.4 billion (+5.9% year over year) and diluted EPS of $2.92. It usually reports 7–30 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 28, 2027.
Results for Q2 FY2027, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Jan 29, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 7–30 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q1 FY2027
ended Sep 30, 2026
|
1,415
+5.9%
|
418
+20.0%
|
2.92
+23.2%
|
|
Jul 7, 2026
7 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
1,464
+8.6%
|
383
+1.0%
|
2.64
+2.3%
|
|
Apr 30, 2026
30 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
1,431
+10.8%
|
399
+9.2%
|
2.74
+10.5%
|
|
Jan 29, 2026
29 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
1,423
+11.0%
|
393
+13.9%
|
2.68
+14.5%
|
|
Oct 30, 2025
30 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
1,336
+9.1%
|
349
+11.9%
|
2.37
+12.3%
|
|
Jul 31, 2025
31 days after quarter end
|
Q4 FY2025
ended Jun 30, 2025
|
1,348
+10.2%
|
380
+29.9%
|
2.58
+30.4%
|
|
Apr 23, 2025
23 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
1,292
+7.9%
|
365
+21.5%
|
2.48
+21.6%
|
|
Jan 30, 2025
30 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
1,282
+10.3%
|
345
+65.0%
|
2.34
+64.8%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RMD (NYSE), RSMDF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 943819
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.